Beranda › Sindrom Mielodisplastik › New Hampshire
Uji klinis Sindrom Mielodisplastik di New Hampshire
5 studi untuk Sindrom Mielodisplastik mencari peserta di lokasi di New Hampshire.
Teks studi resmi (Bahasa Inggris)
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
- Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center, Lebanon
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT05564390Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
- Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center, Lebanon
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT06577441The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center, Lebanon
Menerima pesertaFase 1/2
Hingga usia 22 · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT04726241Genomically Profiling, Collecting, Archiving and Distributing Hematologic Malignancy Specimens
- Dartmouth-Hitchcock, Lebanon
Menerima pesertaStudi observasional
Hingga usia 30 · Semua jenis kelamin · Diperbarui 16 Jul 2026 · NCT04968834Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome
- Dana Farber/New Hampshire Oncology-Hematology, Londonderry
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 7 Mei 2026 · NCT02269592Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.